Hah ah .. how quickly the sordid past of our respected institutions is forgotten .. This is about the aspirin wars .. for heart disease, cf the Heart disease wars re Dean Ornish, when anyone saying heart disease can be reversed and/ or cured without surgery was pooh poohed
Congress also tried, in the 90's, to reclassify all vitamins as drugs.. by prescription only - that one was defeated, pfft
Anyway re aspirin, just for kicks
Everyday Drug That Prevents Cancer Death - Life Extension
" ..
Back in 1983, the Life Extension Foundation® analyzed findings from published studies indicating that low-dose aspirin can
reduce the risk of a heart attack by about 40%.68 Life Extension members were urged to take low-dose aspirin every day to protect against heart attacks.
The FDA and medical establishment were harshly critical of Life Extension’s recommendation, even though peer-reviewed scientific studies substantiated it. The FDA issued an edict that any company that promoted the sale of aspirin to prevent heart attacks would be subject to civil and criminal penalties. According to the FDA, making a health claim for aspirin turned it into an “unapproved drug.”
In response to the FDA’s censorship of health claims about aspirin, Life Extension developed a product called
“First Amendment Aspirin.” On the label of this product was a quote from a published study indicating that aspirin reduces heart attack risk.
The FDA demanded that the sale of this product cease, but Life Extension refused, citing the First Amendment guarantee of free speech, i.e., the right to communicate that a published scientific study found that aspirin reduces heart attack risk. Realizing that they could not get around the US Constitution, the FDA went to the manufacturer of the product and demanded that they stop making “First Amendment Aspirin” or face intrusive daily inspections. The manufacturer capitulated and stopped making the product.
As new studies continued to verify aspirin’s cardioprotective effect, FDA rulings starting in 1998 allowed companies to advertise the cardiovascular benefits of aspirin on a very
limited basis. The FDA added so much bureaucratic red tape about
who the agency thinks should take aspirin that most people don’t find out they need it until it is too late.
It took the FDA 15 years to acknowledge what was clearly established in 1983 about aspirin’s ability to reduce heart attack risk. To this day, the FDA continues to censor what aspirin manufacturers are permitted to say about its effects in reducing cardiac and ischemic stroke events.
In preparing this article, we found studies indicating anti-cancer mechanisms of aspirin dating back to the year 1972,69-71 with significant human data published in 1991.72,73 The failure of the FDA to allow widespread promotion of low-dose aspirin for prevention has clearly resulted in millions of premature deaths. .."
